KG Bio

KG Bio is a life sciences company in Jakarta, Indonesia, founded in 2015. It has raised $55.0M across 1 round, most recently a $55.0M Series C in January 2021.

Bringing Biologics Medical Innovation to International Market

Headquarters
Jakarta
Founded
2015
Business Model
B2B
Total Funding
$55.0M
Last Round
$55.0M Series CJan 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

KGbio (PT Kalbe Genexine Biologics) is a clinical-stage biotechnology company backed by Kalbe Farma of Indonesia and Genexine of South Korea, formed as a joint venture in 2015. It focuses on in-licensing and out-licensing biologics and biosimilars in oncology and other high-specialty therapeutic areas, and also provides cGMP contract development and manufacturing services as a pioneer of biopharmaceutical CDMO work in Indonesia.

Summary

It has raised $55.0M in total across 1 round, most recently a $55.0M Series C round in Jan 2021. Investors include General Atlantic.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJan 2021
$55.0M

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KG Bio on Indexed.vc
<a href="https://indexed.vc/companies/kalbe-genexine-biologics"><img src="https://indexed.vc/api/badge/company/kalbe-genexine-biologics" alt="KG Bio on Indexed.vc" width="260" height="76" /></a>